Timothy Bush
Foot & Ankle Surgery · Nashville, TNNPI 1285920108
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 259 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Smith+Nephew at 49.5% of the total.
Across 259 payments — averaging $25.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Organogenesis Inc.$1K
- Stryker$961
- Aroa Biosurgery Incorporated$519
- Convatec Inc.$244
- Acell, Inc.$142
- plus $436 from 9 others
What the payments were for
- Food & beverage$6,55099%
- Education$991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 162 | $3,290 |
| Organogenesis Inc. | 40 | $1,058 |
| Stryker | 17 | $961 |
| Aroa Biosurgery Incorporated | 10 | $519 |
| Convatec Inc. | 8 | $244 |
| Acell, Inc. | 2 | $142 |
| Osiris Therapeutics Inc. | 10 | $118 |
| Cerapedics Inc. | 1 | $99 |
| Polynovo North America LLC | 2 | $60 |
| Zimmer Biomet | 2 | $49 |
| Amgen | 1 | $29 |
| Acera Surgical, Inc. | 1 | $24 |
| Biocomposites Inc | 1 | $23 |
| Innocoll Pharmaceuticals Limited | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,648 in reported general payments places this provider in the 65th percentile of 145 foot & ankle surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 83 | $2,010 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 105 | $982 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 39 | $873 |
| Cephalexin | 108 | $838 |
| Gabapentin | 104 | $765 |
| Naproxen | 118 | $740 |
| Betamethasone Valerate | 18 | $615 |
| Ammonium Lactate | 20 | $484 |
| Nystatin | 24 | $445 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 94 | $347 |
| Doxycycline Monohydrate | 38 | $319 |
| NystopNystatin | 13 | $286 |
| Methylprednisolone | 46 | $269 |
| Pregabalin | 20 | $141 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $137 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Nashville
- William CornNashville$52K
- Sheela ChockalingamNashville$15K
- Christopher DreikornNashville$13K
- Andrew PierreNashville$10K
- Bethany GallagherNashville$8K
- Jeffrey WillersNashville$7K
- Reva BorkNashville$7K
- Nicholas FussellNashville$6K
- Jeffrey HerringNashville$5K
- Sebastien DemoinyMorristown$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.